Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Fidelity

BIVRX Expense Ratio & Fees

Ticker BIVRX · Since 2017-06-19 · · Holdings as of Jul 31, 2026

Expense ratio
3.3%$330/yr per $10k
5-yr return
+21.6%annualized
1-yr return
+4.4%as of Dec 2025
Net assets
$854.8Mall share classes
Holdings
219

Bottom line

What is BIVRX's expense ratio?

BIVRX's expense ratio is 3.3%, or about $330 a year on every $10,000 invested. That is more expensive than 99% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Mar 2, 2026

BIVRX fee table

Net expense ratio3.3%
Gross expense ratio3.32%
Management fee1.74%
12b-1 (distribution) fee0.25%
Other expenses1.32%
Acquired fund fees0.01%
Fee waiver / reimbursement-0.02%
Max front-end sales load0%
Max deferred sales charge0%
Redemption fee-1%

Source: Fund prospectus fee table, filed Mar 2, 2026

What BIVRX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
BIVRX$333$1,019$1,729$3,611

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 3.3% expense ratio costs roughly $150,300 in lost growth, versus about $46,700 for the median large blend fund (0.83%).

Cheapest way to own Invenomic Fund

All share classes
TickerClassExpense ratioFront load
BIVSXInvenomic Fund Super Institutional Class shares2.8%0%
BIVIXInvenomic Fund Institutional Class shares3.05%0%
BIVRXInvenomic Fund Investor Class shares3.3%0%